Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YF_PROTECT prophylactic sofosbuvir with yellow fever vaccination
NL-OMON58941Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2024
- Modality
- Small Molecules, Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of sofosbuvir and 17D yellow fever vaccine in yellow fever (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: YF17D viremia in plasma, YF17D viruria in urine and 1 more. Started Sep 2024; status: completed.
02
Drugs
sofosbuvir17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NL-OMON58941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58941.